There are errors in the images for Figs 1–5. The x-axis labels in Figs 1 and 2 and the legends in Figs 3 and 4 should be in English. The legend for Fig 5 is missing. Please see the correct Figs 1–5 here.


Prevalence rates of anti-HAV IgG (A), HBsAg (B), anti-HBc IgG (C), anti-HBs ≥10 mUI/ml (D) and anti-HEV IgG (E) by age groups in different regions of Peru.


Prevalence rates of anti-HAV IgG (A), HBsAg (B), anti-HBc IgG (C), anti-HBs ≥10 mUI/ml (D) and anti-HEV IgG (E) by age groups in urban and rural areas of Peru.

![Prevalence of HBsAg and hepatitis Delta before (A) [19] and after the implementation of the hepatitis B vaccination program in Peru (B).](/dataresources/secured/content-1766022408762-2c6ee90d-e0d8-4e71-8c4f-dd21542092d4/assets/pone.0250185.g003.jpg)
Prevalence of HBsAg and hepatitis Delta before (A) [19] and after the implementation of the hepatitis B vaccination program in Peru (B).


Prevalence of anti-HBc IgG after the implementation of the hepatitis B vaccination program in Peru.


Prevalence of anti-HEV IgG in Peru, 2014–2015.
The publisher apologizes for the errors.
1